History
The company was founded in 1863 as "Teerfarbenfabrik Meister, Lucius & Co." in Höchst, near Frankfurt and changed its name some years later to "Teerfarbenfabrik Meister Lucius & Brüning". In 1880 it became a stock company "Farbwerke vorm. Meister Lucius & Brüning AG". For the international market the name was simplified to "Farbwerke Hoechst AG". Until 1925 the Hoechst AG was independent. In 1916, the Hoechst AG was one of the co-founders of IG Farben, a pressure group of Germany's chemicals industry to gain industrial power during and after World War I. In 1925, IG Farben turned from a pressure group into the well-known conglomerate.
World War II - Various Hoechst facilities were bombed during the Oil Campaign of World War II Its managers in charge were defendants, as the other IG Farben managers, in the Nuremberg trial against the company for its role in the exploitation of enslaved laborers and for testing drugs on concentration camp prisoners.
1951 - Hoechst AG was re-founded on December 7 in Frankfurt when IG Farben was split into its founder companies. The original capitalization of the company was 100,000 Deutsche Mark. By 1953 Hoechst had acquired parts of Knapsack-Griesheim, Kalle AG, Behring Werke, Wacker Chemie and Ruhr Chemie, among others.
1969 - Hoechst acquired Cassella.
1987 - Hoechst acquired the American chemical company Celanese and formed a new Hoechst subsidiary in the US, Hoechst Celanese.
1994 - The U.S. National Right to Life Committee announced a U.S. boycott of all Hoechst pharmaceutical products including Altace because of the abortion pill RU-486.
1994 (September 17) - Pharmacists For Life International joins the international boycott, "...against the American subsidiary of Hoechst, AG Hoechst-Roussel, Hoechst-Celanese, its generic subsidiary Copley Pharmaceutical, Inc. and the agricultural Hoechst subsidiary" while asking U.S. consumers to "focus on key Hoechst drugs which have the most economic impact rather than taking an across-the-board shotgun approach" and specifically listing Altace as a boycott list item.
1995 - Hoechst merges with Marion Merrell Dow of Kansas City, Missouri forming U.S. subsidiary Hoechst Marion Roussel (HMR). Altace was bringing in under $90 million in revenues for Hoechst and Hoechst had stopped promoting Altace within the United States.
1995 - The King Pharmaceuticals President Jefferson "Jeff" Gregory first begins negotiations with Hoechst to acquire U.S. distribution rights to Altace.
1997 - Hoechst underwent a realignment wherein its various businesses were transferred to independent companies, including Nutrinova and Clariant.
1997 (April 2) - The pro-life group Concerned Women For America announces at a National Right To Life Committee press briefing at the National Press Club that the anti-RU486 boycott against the U.S. subsidiaries of Hoechst AG & Roussel Uclaf by the NRTLC "...will be more narrowly focused onto the HMR prescription drugs Allegra, Cardizem, Seldane, Claforan, Lasix, Diabeta, and Nicoderm" - and Altace is auspiciously no longer included by Concerned Women For Americas as a boycotted Hoechst Marion Roussel product.
1998 (December 18) - The King Pharmaceuticals wholly owned subsidiary Monarch Pharmaceuticals, Inc. acquires ownership of U.S. distribution rights to Altace and other Hoechst products from Hoechst AG subsidiary Hoechst Marion Roussel of Kansas City, Missouri.
1999 (December 7) - Hoechst and Rhone-Poulenc Settle Federal Trade Commission charges that merger would violate U.S. antitrust laws;
1999 - Aventis was formed when Hoechst AG merged with Rhône-Poulenc S.A. The merged company was headquartered in Strasbourg, Eastern France. As part of the merger, the company demerged many of its industrial businesses into Celanese, which became an independent company again (e.g. the Engineering Polymers business Ticona).
2005 - The company became a wholly owned subsidiary of Sanofi-Aventis (now called Sanofi).
Read more about this topic: Hoechst AG
Famous quotes containing the word history:
“Don’t give your opinions about Art and the Purpose of Life. They are of little interest and, anyway, you can’t express them. Don’t analyse yourself. Give the relevant facts and let your readers make their own judgments. Stick to your story. It is not the most important subject in history but it is one about which you are uniquely qualified to speak.”
—Evelyn Waugh (1903–1966)
“The awareness that health is dependent upon habits that we control makes us the first generation in history that to a large extent determines its own destiny.”
—Jimmy Carter (James Earl Carter, Jr.)
“Throughout the history of commercial life nobody has ever quite liked the commission man. His function is too vague, his presence always seems one too many, his profit looks too easy, and even when you admit that he has a necessary function, you feel that this function is, as it were, a personification of something that in an ethical society would not need to exist. If people could deal with one another honestly, they would not need agents.”
—Raymond Chandler (1888–1959)